Prenetics Global Limited Class A Ordinary Share (PRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,806 | -64,777 | -190,453 | -3,307 | 936,748 |
| Depreciation Amortization | 5,929 | 7,794 | 7,543 | N/A | 25,912 |
| Accounts receivable | -563 | 37,633 | 6,966 | N/A | N/A |
| Accounts payable and accrued liabilities | -4,682 | -5,618 | -2,628 | 274 | 383,841 |
| Other Working Capital | 1,965 | 24,210 | -33,764 | 2,571 | 907,704 |
| Other Operating Activity | 18,283 | -13,007 | 226,850 | -910 | -1,255,336 |
| Operating Cash Flow | $-28,874 | $-13,765 | $14,515 | $-1,373 | $998,869 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,000 | 3,920 | -19,920 | N/A | -504,145 |
| PPE Investments | -964 | -246 | -4,898 | N/A | N/A |
| Net Acquisitions | -8,346 | N/A | -3,419 | N/A | N/A |
| Purchase Of Investment | 29,871 | -90,002 | -20,000 | -339,342 | -17,224,840 |
| Sale Of Investment | N/A | N/A | 3,005 | N/A | 17,705,250 |
| Purchase Sale Intangibles | -59 | -567 | -1,395 | N/A | N/A |
| Other Investing Activity | 1,980 | 3,376 | -913 | 0 | -94,259 |
| Investing Cash Flow | $38,541 | $-82,952 | $-46,145 | $-339,342 | $-117,994 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 126 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 496,012 |
| Debt Repayment | N/A | N/A | N/A | N/A | -512,697 |
| Common Stock Issued | N/A | 2 | 117 | 341,342 | 1,159 |
| Common Stock Repurchased | -577 | -1,230 | -662 | N/A | -6,540 |
| Dividend Paid | N/A | N/A | N/A | N/A | -245,802 |
| Other Financing Activity | -2,766 | -3,476 | 143,863 | -651 | 0 |
| Financing Cash Flow | $-3,343 | $-4,704 | $143,319 | $340,817 | $-267,868 |
| Exchange Rate Effect | 221 | 467 | -318 | N/A | -6,451 |
| Beginning Cash Position | 45,706 | 146,660 | 35,289 | N/A | 877,907 |
| End Cash Position | 52,251 | 45,706 | 146,660 | 102 | 1,484,463 |
| Net Cash Flow | $6,545 | $-100,954 | $111,371 | $102 | $606,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,874 | -13,765 | 14,515 | -1,373 | 998,869 |
| Capital Expenditure | -1,006 | -345 | -4,948 | N/A | N/A |
| Free Cash Flow | -29,880 | -14,110 | 9,566 | -1,373 | 998,869 |